Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs),
harboring spike protein N-terminal domain (NTD) or receptor-binding domain (RBD) …

New Jersey was among the first states impacted by the COVID-19 pandemic, with one of the
highest overall death rates in the nation. Nevertheless, relatively few reports have been …

Spike protein mutations E484K and N501Y carried by SARS-CoV-2 variants have been
associated with concerning changes of the virus, including resistance to neutralizing antibodies …

Examining the neutralizing capacity of monoclonal antibodies (MAbs) used to treat COVID-19,
as well as antibodies recovered from unvaccinated, previously vaccinated, and infected …

New Jersey was an early epicenter for the COVID-19 pandemic in the United States, yet
information on hospitalized COVID-19 patients from this area is scarce. This study aimed to …

Fludarabine, cyclophosphamide, and rituximab (FCR) remains the standard of care for fit
chronic lymphocytic leukemia (CLL) patients requiring first therapy. However, side effects can …

Fungal infections are common complications of respiratory viral infections and are
associated with the increased need for intensive care and elevated mortality. Data regarding …

Emergence of SARS-CoV-2 with high transmission and immune evasion potential, the so-called
variants of concern (VOC), is a major concern. We describe the early genomic …

Subtypes of diffuse large B-cell lymphoma (DLBCL) that have inferior outcomes after front-line
therapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and …

Introduction There is a growing awareness of the molecular heterogeneity of DLBCL beyond
the GC and non-GC well established subtypes. “Double-hit” lymphoma (DHL) harboring …